With regard to therapeutics, although the SMAC mimetic and IAP agonist BV6 has demonstrated potential for inducing cell death in a large number of cancers, it was shown to induce accumulation of NIK, resulting in increased cell elongation, migration, and invasion in primary glioblastoma cells [85]. Here, MAP3K14 is linked to cancer.